TY - CONF A1 - Resch-Genger, Ute A1 - Wegner, Karl David A1 - Kalot, G. A1 - Busser, B. A1 - Pliquett, J. A1 - Köster, U. A1 - Koll, J. C. A1 - Denat, F. A1 - Bodio, E. A1 - Goze, C. A1 - Sacey, L. T1 - NIR aza-BODIPY: a new vector for boron neutron capture therapy (BNCT) N2 - Boron neutron capture therapy (BNCT) relies on the activation of 10B by thermal neutrons, which results in small highly energetic particle emission inducing cancer cells damage. However, in order to overcome the limits of the currently used BNCT agents, it is necessary to design new systems, which can specifically accumulate and deliver a sufficient amount of 10B in tumors. In this study, we designed a 10B-BSH-containing aza-BODIPY (aza-SWIR-BSH). It enabled the efficient vectorization of clinically used 10B-BSH to the tumor, resulting in higher therapeutic activity than the 10B-BSH alone. T2 - EMIM 2021 CY - Göttingen, Germany DA - 24.08.2021 KW - Flourescence KW - Optical probe KW - Dye KW - Photophysics KW - Quantum yield KW - Mechanism KW - NIR KW - SWIR KW - Imaging KW - Method KW - Quality assurance KW - BODIPY KW - Boron Neutron Capture Therapy (BNCT) KW - Medicine KW - Life sciences PY - 2021 AN - OPUS4-53731 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -